Sustainable Endotoxin Testing: rCR Chromogenic Assay from China Suppliers & Factory for Reliable Detection
Products Features
The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.
Sustainable & Animal-Free
By utilizing recombinant technology, RCR eliminates dependency on horseshoe crab blood, supporting conservation efforts and promoting animal welfare without compromising reagent supply.
Enhanced Specificity
Unlike native LAL reagents, RCR is not activated by (1→3)-β-D-glucans, eliminating false-positive results and significantly improving test accuracy in complex pharmaceutical matrices.
Regulatory Compliance
RCR is supported by emerging pharmacopeial standards, such as the proposed USP <86> chapter "Bacterial Endotoxins Test Using Recombinant Reagents," facilitating adoption in regulated environments.
Proven Applicability
Demonstrated compatibility across real-world pharmaceutical products, yielding comparable and reliable results to traditional LAL-based methods.
Frequently Asked Questions
What is Recombinant Cascade Reagent (RCR)?
RCR is a highly specific, animal-free recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL) used for bacterial endotoxin testing.
How does RCR support animal welfare?
RCR is produced using recombinant technology, which eliminates the dependency on horseshoe crab blood, thereby protecting marine ecosystems and supporting conservation efforts.
Does RCR mirror the reaction mechanism of native LAL?
Yes, the recombinant cascade—comprising recombinant Factor C, Factor B, and proclotting enzyme—ensures a reaction pathway that closely mimics native LAL, leading to high correlation in test results.
How does RCR prevent false-positive results?
Unlike native LAL, RCR is not activated by (1→3)-β-D-glucans, which are common sources of false-positive results in certain pharmaceutical samples.
Is RCR compliant with pharmacopeial standards?
Yes, its use is supported by emerging standards, including the proposed USP <86> chapter titled "Bacterial Endotoxins Test Using Recombinant Reagents," facilitating its integration into regulated environments.